Berenberg Downgrades Smith & Nephew (SNN) to Hold
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Berenberg downgraded Smith & Nephew (NYSE: SNN) from Buy to Hold with a GBP13.40 price target.
Analyst Tom Jones commented, "Smith & Nephew has gradually de-emphasised its slower growth areas and implemented various cost-savings measures, reinvesting the proceeds in faster growth areas of the business. However, the success of this strategy has been largely offset by various missteps and one-off headwinds, a trend we expect to continue. We have therefore become more cautious about the organic revenue growth outlook for the company, as well as on margins and earnings growth. We do expect accelerating earnings growth in 2017E, to 12% in fact, but 3ppt of this is dependant on an as yet unannounced buyback and is far from certain. Hence we no longer expect a large enough inflection in earnings growth of sufficient quality to drive the stock higher and reduce our rating to Hold."
Shares of Smith & Nephew closed at $32.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA/Merrill Lynch Upgrades CF Industries (CF) to Buy, Says "Consensus Estimates Now Beatable"
- UPDATE: SunTrust Robinson Humphrey Downgrades Pennsylvania Real Estate Investment Trust (PEI) to Hold
- IBM (IBM): Closer Look Shows The - Jefferies
Create E-mail Alert Related CategoriesAnalyst Comments, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!